Blue Horizon Enterprise Ltd
SEC CIK 1869057 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | 10% | 6.91M | — | $91.98M | 3 | 2024-04-17 | 2024-12-23 |
Most active insiders at STOK, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Krainer Adrian R. | Dir | — | $3.90M |
| 2 | Kaye Edward M. MD | Dir | — | $3.18M |
| 3 | Ticho Barry | Chief MEDICAL Off | — | $1.98M |
| 4 | Allan Jonathan | GC, CORP SEC | — | $1.56M |
| 5 | TZIANABOS ARTHUR | Interim Executive COB, Dir | — | $174.2K |
| 6 | Leggett Thomas | CFO | — | $147.1K |
| 7 | Hoitt Jason | Chief Patient Off | — | $119.3K |
| 8 | LEVIN ARTHUR A | Dir | — | $22.3K |
Blue Horizon Enterprise Ltd made no open-market trades at STOK in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-12-27 | 2024-12-23 | STOK | Stoke Therapeutics, Inc. | Blue Horizon Enterprise Ltd | 10% | S - Sale | $11.50 | -2.00M | 6.91M | -22% | -$23.00M |
| I | 2024-09-23 | 2024-09-19 | STOK | Stoke Therapeutics, Inc. | Blue Horizon Enterprise Ltd | 10% | S - Sale | $14.05 | -1.94M | 8.91M | -18% | -$27.22M |
| I | 2024-04-18 | 2024-04-17 | STOK | Stoke Therapeutics, Inc. | Blue Horizon Enterprise Ltd | 10% | S - Sale | $11.60 | -3.60M | 10.84M | -25% | -$41.76M |
Purchase Sale Sale after option exercise All abbreviations